Thrombus in cerebral large vessel

A **thrombus in an intracranial large vessel** is a mass of aggregated platelets, fibrin, red and white blood cells forming within a major artery or vein of the brain. This occlusion blocks blood flow, causing neuronal death due to ischemia, and is the principal cause of large-vessel ischemic stroke and cerebral venous sinus thrombosis. Management is focused on rapid revascularization to restore perfusion, using thrombolytic agents, anticoagulants, or mechanical thrombectomy, according to vessel type and clinical scenario[3][1][5][6]. This entity is not a molecule or receptor itself, but the physical and pathological obstruction it creates is the clinical target for therapeutic intervention. This entry is *incorrect as a molecular target* under standard drug discovery classification. The correct drug targets in this disease context are molecules involved in coagulation, platelet aggregation, or fibrinolysis, not the thrombus itself. For structured, canonical target data, one should specify a molecular target (e.g., "platelet glycoprotein IIb/IIIa" or "fibrin") rather than the clot as a whole.

Other names

Cerebral thrombusLarge vessel intracranial thrombusIntracranial large artery thrombosis

Thrombolysis: Enzymatic breakdown of fibrin mesh within the thrombus via thrombolytic drugs; Anticoagulation: Inhibition of coagulation cascade to limit additional clot growth; Antiplatelet activity: Inhibition of platelet aggregation to prevent further thrombosis